TrialDiabetic medicine : a journal of the British Diabetic Association2017

Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial (BOOST

I B Hirsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.